Abstract:
본 발명은 육두구 추출물을 유효성분으로 함유하는 비만 예방 및 치료용 약학 조성물에 관한 것이다. 본 발명은 육두구 추출물에 의해서 고지방 식이의 섭취로 인하여 유발되는 체중증가 억제, 난소주위 지방중량 증가억제 및 주로 지방 세포의 비대에 의해 초래되는 복부지방의 축적을 억제함으로써, 고지방 식이의 섭취에 의해 유발되는 비만 예방 및 치료용 약학조성물로 유용하게 이용될 수 있다. 육두구, 비만
Abstract:
PURPOSE: Functional food containing eugenia caryophyllata extract is provided to protect tissue of liver while restricting enzyme activity of alanine aminotransferase and aspartate aminotransferase in blood, and to restrict accumulation of fat in liver. CONSTITUTION: Functional food preventing liver damage caused by high fat and improving liver function contains eugenia caryophyllata extract. The functional food further contains mixed herbal mixtures of cinnamomi Cortex, myristicae Semen, gambir, aurantii nobilis Pericarpium, atractylodis Rhizoma, magnoliae Cortex, corydalis Tuber and Capsicum annuum. The function food further contains a mixed herb extract mixture.
Abstract:
본 발명은 정향추출물을 유효성분으로 함유하며 고지방 식이의 섭취에 의해 유발되는 간 손상의 예방 및 치료용 약학 조성물에 관한 것이며, 또한 본 발명은 고지혈증 치료와 동시에 고지혈증 약물 투여에 의해 손상되는 간을 보호하는 간 보호제에 관한 것이다. 본 발명은 정향추출물에 의해서 고지방 식이의 섭취로 인하여 간에 지방이 축적되어 간의 손상이 초래되는 것을 억제하며, 혈중 아스파테이트 아미노트랜스퍼라제 및 알라닌 트랜스퍼라제의 효소 활성을 억제하고, 간의 조직을 보호함으로써 고지혈증 치료시에 유발되는 부작용인 간 손상을 보호하는데 유용하게 이용될 수 있다. 정향, 고지혈증, 간손상
Abstract:
PURPOSE: Functional food containing eugenia caryophyllata extract is provided to protect tissue of liver while restricting enzyme activity of alanine aminotransferase and aspartate aminotransferase in blood, and to restrict accumulation of fat in liver. CONSTITUTION: Functional food preventing liver damage caused by high fat and improving liver function contains eugenia caryophyllata extract. The functional food further contains mixed herbal mixtures of cinnamomi Cortex, myristicae Semen, gambir, aurantii nobilis Pericarpium, atractylodis Rhizoma, magnoliae Cortex, corydalis Tuber and Capsicum annuum. The function food further contains a mixed herb extract mixture.
Abstract:
PURPOSE: Functional food containing extract of myristica fragrans houttuyn is provided to prevent and improve obesity symptoms due to high fat diet by using the extract of the myristica fragrans houttuyn and herbal medicine extract. CONSTITUTION: Functional food for improvement and prevention of obesity symptoms contains the extract of myristica fragrans houttuyn. The functional food for the obesity symptom improvement and prevention further contains a herbal medicine extract mixture of cinnamomi Cortex, caryophylli Flos, gambir, aurantii nobilis Pericarpium, atractylodis Rhizoma, magnoliae Cortex, corydalis Tuber and Capsicum annuum. The form of the functional food is a pill, a granule, a capsule or liquid type. The functional food is a drink or tea-type.
Abstract:
PURPOSE: A pharmaceutical composition for treating liver injury caused by treatment of hyperlipidemia, which contains Syzygium aromaticum extract is provided to prevent liver damage by administering drug for hyperlipidemia. CONSTITUTION: A pharmaceutical composition for treating liver injury caused by treatment of hyperlipidemia contains Syzygium aromaticum extract as an active ingredient. The composition contains cinnamon, Myristica fragrans Houtt, Atractylodis Rhizoma, magnolia obovata, and Corydalis turtschaninovii. The composition further comprises Lindera Root and Glycyrrhiza uralensis extract. The extract is isolated through freeze-drying or spray drying.
Abstract:
PURPOSE: A pharmaceutical composition containing Myristica fragrans Houttuyn extract is provided to suppress accumulation of epididymal fat and to prevent and treat obesity. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity contains Myristica fragrans Houttuyn extract as an active ingredient. The composition further contains cinnamomi Cortex, caryophylli Flos, gambir, aurantii nobilis Pericarpium, atractylodis Rhizoma, magnoliae Cortex, corydalis Tuber, or Capsicum annuum. The Myristica fragrans Houttuyn extract is extracted by fluid extract, freeze dry, and spray dry to formulate to liquid, tablet, capsule, suspension, and syrup.
Abstract:
본 발명은 판토프라졸 함유 약제의 경구 투여 형태에 관한 것이다. 특히, 본 발명은 코어, 중간물질 층 및 위액에 내성을 갖는 최외층으로 구성된 판토프라졸 경구 투여 형태에 있어서, 필수적으로 충전제로서 저치환도히드록시프로필셀룰로오스를 사용하므로서 저장 보관시 산 불안정성 약리활성물질인 판토프라졸의 안정성을 증진시킬 수 있다. 판토프라졸, 충전제, 저치환도히드록시프로필셀룰로오스
Abstract:
PURPOSE: Provided is a pharmaceutical composition for antidiarrhea containing loperamide hydrochloride and freeze-dried lactobacillus sp. The pharmaceutical composition has improves intestinal disorders, and acute and chronic diarrhea. CONSTITUTION: The pharmaceutical composition for antidiarrhea is characterized by containing loperamide hydrochloride and 340 wt.% of freeze-dried lactobacillus acidophilus. The composition is formulated into powder, granules, capsules and the like.